Roivant Sciences Ltd (ROIV)
Return on assets (ROA)
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | -171,981 | -116,621 | 4,810,178 | 4,736,035 | 4,348,922 | 4,466,420 | -981,774 | -993,368 | -1,055,336 | -1,313,032 | -1,245,554 | -1,138,114 | -866,513 | -1,084,764 | -1,061,257 | -888,174 | -809,234 | -299,670 |
Total assets | US$ in thousands | 5,436,940 | 5,792,340 | 6,206,030 | 6,496,450 | 7,222,480 | 7,312,680 | 2,065,540 | 2,136,650 | 2,389,600 | 2,202,960 | 2,215,530 | 2,600,400 | 2,585,130 | 2,799,380 | 3,102,910 | 2,454,700 | 2,589,690 | — |
ROA | -3.16% | -2.01% | 77.51% | 72.90% | 60.21% | 61.08% | -47.53% | -46.49% | -44.16% | -59.60% | -56.22% | -43.77% | -33.52% | -38.75% | -34.20% | -36.18% | -31.25% | — |
March 31, 2025 calculation
ROA = Net income (ttm) ÷ Total assets
= $-171,981K ÷ $5,436,940K
= -3.16%
Roivant Sciences Ltd's return on assets (ROA) has shown significant fluctuations over the period from December 31, 2020, to March 31, 2025. The ROA started at an unreported value in December 2020, followed by a sharp decline to -31.25% as of March 31, 2021. This negative trend continued, reaching its lowest point at -59.60% by December 31, 2022.
However, there was a notable turnaround in the company's performance starting from the first quarter of 2023. The ROA saw a positive upturn, reaching 61.08% by December 31, 2023, and further improving to 77.51% by September 30, 2024. This period marked a significant recovery in the company's asset utilization efficiency.
Despite the positive momentum, the ROA decreased slightly to -2.01% by the end of December 2024 and continued to decline to -3.16% as of March 31, 2025. This recent decline may indicate potential challenges in generating profits relative to the assets employed in the business.
Overall, the analysis of Roivant Sciences Ltd's ROA highlights both periods of strong improvement and concerning declines in asset utilization efficiency. It suggests the company's varying ability to generate profits from its assets, indicating the need for a closer examination of its operational performance and financial management strategies.
Peer comparison
Mar 31, 2025